AG
FLGT icon

Algert Global’s Fulgent Genetics FLGT Stock Holding History

Algert Global’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,695
Closed -$360K – 1217
2025
Q4 		$360K Buy
+13,695
New +$355K 0.01% 985
2024
Q4 		– Sell
-81,440
Closed -$1.77M – 1222
2024
Q3 		$1.77M Hold
81,440
– – 0.05% 595
2024
Q2 		$1.6M Buy
81,440
+25,680
+46% +$536K 0.05% 535
2024
Q1 		$1.21M Buy
+55,760
New +$1.38M 0.05% 567
2022
Q1 		– Sell
-3,042
Closed -$306K – 1219
2021
Q4 		$306K Sell
3,042
-300
-9% -$26.4K 0.04% 723
2021
Q3 		$301K Buy
+3,342
New +$304K 0.04% 761
2021
Q2 		– Sell
-4,956
Closed -$479K – 455
2021
Q1 		$479K Sell
4,956
-3,237
-40% -$334K 0.15% 211
2020
Q4 		$427K Buy
+8,193
New +$342K 0.12% 248

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Algert Global's FLGT Position: Q1 2026 in Review

Algert Global sold out of Fulgent Genetics (FLGT) in Q1 2026, closing a stake of 13,695 shares — an estimated $360K sold.

Algert Global first reported a position in FLGT in Q4 2020 and held it in 8 quarters. The position peaked at $1.77M in Q3 2024. 158 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Algert Global reported no remaining Fulgent Genetics position as of Q1 2026 after selling out during the quarter.
  • Algert Global sold 13,695 Fulgent Genetics shares in Q1 2026, an estimated $360K.
  • Algert Global first reported a position in Fulgent Genetics in Q4 2020 and held it in 8 quarters.
  • Algert Global's Fulgent Genetics position peaked at $1.77M in Q3 2024.
  • 158 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.